MIT Department of Biology 
7.014 Introductory Biology, Spring 2005 

Recitation Section 8 
March 2-3, 2005 

Molecular Biology—Transcription and Translation 

Today we return to take another look at the yeast cystathionine beta synthase (CBS) protein. Below is 
the sequence of the yeast CBS gene and surrounding DNA. We will use this sequence for parts A and 
B of today’s section. 

The sequences of both strands of the DNA duplex are shown: the top strand reads 5' to 3' left to right (1 
to 2040); the bottom, complimentary, strand reads 5' to 3' right to left (2040 to 1). 

5’- CAACTTCACCCAAGTAAGGATAATCAGCTCTGTCGTGACTGATAAATGCTATATCCGGCA 
   1 ---------+---------+---------+---------+---------+---------+ 

3’-  GTTGAAGTGGGTTCATTCCTATTAGTCGAGACAGCACTGACTATTTACGATATAGGCCGT 


TATGCAGTCCACACGGCATTACCGTTTCACTAATTTATTGCCATCTTCCTCCACAGTTTT 

  61 ---------+---------+---------+---------+---------+---------+ 

ATACGTCAGGTGTGCCGTAATGGCAAAGTGATTAAATAACGGTAGAAGGAGGTGTCAAAA 




GCACCGAAAGGAAAAAAAGAAACCAACACCGAAAATTTTTTTCTCCTAAAGGTTAAAGTA 
 121 ---------+---------+---------+---------+---------+---------+  

CGTGGCTTTCCTTTTTTTCTTTGGTTGTGGCTTTTAAAAAAAGAGGATTTCCAATTTCAT 







AACGCAAGGCACTTCACCAGGCTTGTATATATAAATGTCGTGATGCTTCTATGCCAAAGT 

 181 ---------+---------+---------+---------+---------+---------+ 

TTGCGTTCCGTGAAGTGGTCCGAACATATATATTTACAGCACTACGAACATACGGTTTCA 


AAAAGGCAACACTTGAAGATTTCGTTGTAGGCCACTTGCTCAAAGGACATCTAGATAAAT 
 241 ---------+---------+---------+---------+---------+---------+ 

TTTTCCGTTGTGAACTTCTAAAGCAACATCCGGTGAACGAGTTTCCTGTAGATCTATTTA 







ACGACGTAAGAATAAAAATGACTAAATCTGAGCAGCAAGCCGATTCAAGACATAACGTTA 

 301 ---------+---------+--------c+--------b+---------+---a-----+ 

TGCTGCATTCTTATTTTTACTGATTTAGACTCGTCGTTCGGCTAAGTTCTGTATTGCAAT 


TCGACTTAGTTGGTAACACCCCATTGATCGCACTGAAAAAATTGCCTAAGGCTTTGGGTA 

 361 ---------+----e----+--d------+---------+---------+---------+ 

AGCTCAATCAACCATTGTGGGGTAACTAGCGTGACTTTTTTAACGGATTCCGAAACCCAT 


TCAAACCACAAATTTATGCTAAGCTGGAACTATACAATCCAGGTGGTTCCATCAAAGACA 
 421 ---------+---------+---------+---------+---------+---------+ 

AGTTTGGTGTTTAAATACGATTCGACCTTGATATGTTAGGTCCACCAAGGTAGTTTCTGT 

GAATTGCCAAGTCTATGGTGGAAGAAGCTGAAGCTTCCGGTAGAATTCATCCTTCCAGAT 
 481 ---------+---------+---------+---------+---------+---------+ 

CTTAACGGTTCAGATACCACCTTCTTCGACTTCGAAGGCCATCTTAAGTAGGAAGGTCTA 

CTACTCTGATCGAACCTACTTCTGGTAACACCGGTATCGGTCTAGCTTTAATCGGCGCCA 
 541 ---------+---------+---------+---------+---------+---------+ 

GATGAGACTAGCTTGGATGAAGACCATTGTGGCCATAGCCAGATCGAAATTAGCCGCGGT 



















TCAAAGGTTACAGAACTATCATCACCTTGCCGGAAAAAATGTCTAACGAGAAAGTTTCTG 
 601 ---------+---------+---------+---------+---------+---------+ 

AGTTTCCAATGTCTTGATAGTAGTGGAACGGCCTTTTTTACAGATTGCTCTTTCAAAGAC 

TCCTAAAGGCTCTGGGTGCTGAAATCATCAGAACTCCAACTGCTGCTGCCTGGGATTCTC 
 661 ---------+---------+---------+---------+---------+---------+ 

AGGATTTCCGAGACCCACGACTTTAGTAGTCTTGAGGTTGACGACGACGGACCCTAAGAG 

CAGAATCACATATTGGTGTTGCTAAGAAGTTGGAAAAAGAGATTCCTGGTGCTGTTATAC 
 721 ---------+---------+---------+---------+---------+---------+ 

GTCTTAGTGTATAACCACAACGATTCTTCAACCTTTTTCTCTAAGGACCACGACAATATG 

TTGACCAATATAACAATATGATGAACCCAGAAGCTCATTACTTTGGTACTGGTCGCGAAA 
 781 ---------+---------+---------+---------+---------+---------+ 

AACTGGTTATATTGTTATACTACTTGGGTCTTCGAGTAATGAAACCATGACCAGCGCTTT 

TCCAAAGACAGCTAGAAGACTTGAATTTATTTGATAATCTACGCGCTGTTGTTGCTGGTG 
 841 ---------+---------+---------+---------+---------+---------+ 

AGGTTTCTGTCGATCTTCTGAAGTTAAATAAAGTATTAGATGCGCGACAACAACGACCAC 

CTGGTACTGGTGGGACTATTAGCGGTATTTCCAAGTACTTGAAAGAACAGAATGATAAGA 
 901 ---------+---------+---------+---------+---------+---------+ 

GACCATGACCACCCTGATAATCGCCATAAAGGTTCATGAACTTTCTTGTCTTACTATTCT 

TCCAAATCGTTGGTGCTGACCCATTCGGTTCAATTTTAGCCCAACCTGAAAACTTGAATA 

961 ---------f---------+---------+---------+---------+---------+ 

AGGTTTAGCAACCACGACTGGGTAAGCCAAGTTAAAATCGGGTTGGACTTTTGAACTTAT 


AGACTGATATCACTGACTACAAAGTTGAGGGTATTGGTTATGATTTTGTTCCTCAGGTTT 

1021 ---------+---------+---------+------g--+---------+---------+ 

TCTGACTATAGTGACTGATGTTTCAACTCCCATAACCAATACTAAAACAAGGAGTCCAAA 


TGGACAGAAAATTAATTGATGTTTGGTATAAGACAGACGACAAGCCTTCTTTCAAATACG 
1081 ---------+---------+---------+---------+---------+---------+ 

ACCTGTCTTTTAATTAACTACAAACCATATTCTGTCTGCTGTTCGGAAGAAAGTTTATGC 

CCAGACAATTGATTTCTAACGAAGGTGTCTTGGTGGGTGGTTCTTCCGGTTCTACCTTCA 
1141 ---------+---------+---------+---------+---------+---------+ 

GGTCTGTTAACTAAAGATTGCTTCCACAGAACCACCCACCAAGAAGGCCAAGATGGAAGT 

CTGCGGTTGTGAAATACTGTGAAGACCACCCTGAACTGACTGAAGATGATGTCATTGTTG 
1201 ---------+---------+---------+---------+---------+---------+ 

GACGCCAACACTTTATGACACTTCTGGTGGGACTTGACTGACTTCTACTACAGTAACAAC 

CCATATTCCCAGATTCCATCAGGTCGTACCTAACCAAATTCGTCGATGACGAATGGTTGA 
1261 ---------+---------+---------+---------+---------+---------+ 

GGTATAAGGGTCTAAGGTAGTCCAGCATGGATTGGTTTAAGCAGCTACTGCTTACCAACT 

AAAAGAACAATTTGTGGGATGATGACGTGTTGGCCCGTTTTGACTCTTCAAAGCTGGAGG 
1321 ---------+---------+---------+---------+---------+---------+ 

TTTTCTTGTTAAACACCCTACTACTGCACAACCGGGCAAAACTGAGAAGTTTCGACCTCC 

CTTCGACGACAAAATACGCTGATGTGTTTGGTAACGCTACTGTAAAGGATCTTCACTTGA 
1381 ---------+---------+---------+---------+---------+---------+ 

GAAGCTGCTGTTTTATGCGACTACACAAACCATTGCGATGACATTTCCTAGAAGTGAACT 









































































AACCGGTTGTTTCCGTTAAGGAAACCGCTAAGGTCACTGATGTTATCAAGATATTAAAAG 
1441 ---------+---------+---------+---------+---------+---------+ 

TTGGCCAAGAAAGGCAATTCCTTTGGCGATTCCAGTGACAACAATAGTTCTATAATTTTC 

ACAATGGCTTTGACCAATTGCCTGTGTTGACTGAAGACGGCAAGTTGTCTGGTTTAGTTA 
1501 ---------+---------+---------+---------+---------+---------+ 

TGTTACCGAAACTGGTTAACGGACACAACTGACTTCTGCCGTTCAACAGACCAAATCAAT 

CTCTCTCTGAGCTTCTAAGAAAACTATCAATCAATAATTCAAACAACGACAACACTATAA 
1561 ---------+---------+---------+---------+---------+---------+ 

GAGAGAGACTCGAAGATTCTTTTGATAGTTAGTTATTAAGTTTGTTGCTGTTGTGATATT 

AGGGTAAATACTTGGACTTCAAGAAATTAAACAATTTCAATGATGTTTCCTCTTACAACG 
1621 ---------+---------+---------+---------+---------+---------+ 

TCCCATTTATGAACCTGAAGTTCTTTAATTTGTTAAAGTTACTACAAAGGAGAATGTTGC 

AAAATAAATCCGGTAAGAAGAAGTTTATTAAATTCGATGAAAACTCAAAGCTATCTGACT 
1681 ---------+---------+---------+---------+---------+---------+ 

TTTTATTTAGGCCATTCTTCTTCAAATAATTTAAGCTACTTTTGAGTTTCGATAGACTGA 

TGAATCGTTTCTTTGAAAAAAACTCATCTGCCGTTATCACTGATGGCTTGAAACCAATCC 
1741 ---------+---------+---------+---------+---------+---------+ 

ACTTAGCAAAGAAACTTTTTTTGAGTAGACGGCAATAGTGACTACCGAACTTTGGTTAGG 

ATATCGTTACTAAGATGGATTTACTGAGCTACTTAGCATAAATAAGAACCCACGCTTCAA 

1801 ---------+---------+---------+---------+---------+---------+ 

TATAGCAATGATTCTACCTAAATGACTCGATGAATCGTATTTATTCTTGGGTGCGAAGTT 


ATAAAAGCAAACATAGAAGCAAAATCCGTCATTCCTTTCCTATTCAATTGCACCGTTCTC 
1861 ---------+---------+---------+---------+---------+---------+ 

TATTTTCGTTTGTATCTTCGTTTTAGGCAGTAAGGAAAGGATAAGTTAACGTGGCAAGAG 

TTTATATAACTACTTAATTAAATAGCGCCTATACGAAGCAGCATTGTTCTATTATTTTTA 
1921 ---------+---------+---------+---------+---------+---------+ 

AAATATATTGATGAATTAATTTATCGCGGATATGCTTCGTCGTAACAAGATAATAAAAAT 

CAAATTCCTTATCATGCATGCATCACATCAGTGTTTGAATCTGTTAACTTTTCACTTTAT 
1981 ---------+---------+---------+---------+---------+---------+ 

GTTTAAGGAATAGTACGTACGTAGTGTAGTCACAAACTTAGACAATTGAAAAGTGAAATA 























































A.  Transcription and Translation—Practice 

RNA Polymerase complex binds to the two TATA-type elements underlined and bolded above. Once 
bound, RNA polymerase starts making mRNA somewhere between 40 and 120 base pairs downstream 
of the last TATA element.  

1.  If transcription starts 40 base pairs downstream of the last TATA element, at base pair #253, 
write the sequence of the first 10 nucleotides of the resulting mRNA. Label 5’ and 3’ ends. 

2.  If transcription starts 90 base pairs downstream of the last TATA element, at base pair #303, 
write the sequence of the first 10 nucleotides of the resulting mRNA. Label 5’ and 3’ ends. 

3.  In each case, what are the first eight amino acids of the resulting protein? In this case, does the 
transcription start site influence the sequence of the resulting protein? 

4.  Does translation terminate at the TAA at the underlined position 353 (a)? Why or why not? 

5.  How would your answer to 3 change if the C/G base pair at position 339 (b, bold) was deleted? 
What effect, if any, do you expect this mutation to have on the resulting CBS protein? 

6.  How would your answer to 3 change if an A/T base pair was added between 328 & 329 (c, 
bold)? What effect, if any, do you expect this mutation to have on the resulting CBS protein? 

7.  How would your answer to 3 change if the A/T base pair at position 383 (d, bold) were changed 
to a G/C? What effect, if any, do you expect this mutation to have on the resulting CBS 
protein? 

8.  Give a single base change (substitution, deletion, or addition of a single base and it's partner on 
the other strand) that would cause termination of the polypeptide chain at TAA codon 374 (e, 
underlined). 

9.  Give an example of a nonsense mutation (codon --> stop codon). 

10. Give an example of missense  mutation (codon --> codon for another amino acid). 

11. Give an example of silent mutation (codon ---> codon for the same amino acid). 

12. A mutation in what codon(s) always results in a change in the primary sequence of the resulting 
protein? 

13. The actual stop codon for CBS is at bases 1839-1841 (underlined). What would the effect of 
the A1841C mutation be on the CBS protein? 

B.  Transcription and Translation—Functional effects 

Recall that yeast that lack CBS protein can not synthesize the amino acid cysteine. Mutant versions of 
the human CBS protein can lead to a very serious disease called homocystinuria. Some symptoms 
include mental retardation, early strokes and heart disease.  

Recall also that in Section 3 we encountered a crystallographic model of a form of CBS protein. 
Consider the model again. This model is of a truncated form of the human CBS protein. Yeast and 
human proteins are very similar (72%), and some sections are identical (38%).  

I. Mutation 1-- Treatable 

1.  Take a look at bases 969-971 (f, bold). 
a.  What amino acid is encoded? 

b.  What kind of amino acid is it? 

c.  Where in a protein might you expect to find it? 

In the human CBS protein, this amino acid corresponds to Ile278.  

2.  What type of amino acid is Ile? Would you expect to find it in the same environment as the 
amino acid in 1 or not? Explain. 

Choose “Isoleucine 278” on the crystallographic model exercise.  

3.  What type of secondary structure element is it located in? 

4.  What type of amino acids would you expect to surround it? 

Choose “Isoleucine 278 and Neighbors” on the crystallographic model exercise. 

5.  What amino acids is Ile278 in contact with? 

6.  What type of amino acids are those? 

A human mutation leading to a serious but somewhat treatable case of homocystinurea is caused by the 
equivalent of G969A and T970C mutations in yeast. 

7.  What amino acid would be created in yeast with those substitutions? 

8.  Is a mutation causing this amino acid substitution more likely in humans or in yeast? Why? 

9.  What would be the effect of this mutation be on the tertiary structure of CBS? Why? 

The only known treatment  for homocystinurea is to supplement patient’s diet with large quantities of 
vitamin B6. B6 is the co-factor for human CBS.  

10. In general, why would adding more co-factor to a deficient enzyme help restore some of the 
function? 

11. How do you suppose does the treatment overcome the deficiency in the mutant CBS? 

II. Mutation 2-- Untreatable 

12. Take a look at bases 1056-1058 (g, bold). 
a.  What amino acid is encoded? 

b.  What kind of amino acid is it? Does it have any special properties? 

c.  Where in a protein might you expect to find it? 

In the human CBS protein, this amino acid corresponds to Gly307. Choose “Glycine 307” on the 
crystallographic model exercise.  

13. Does it belong to any secondary structure element? 

14. What type of amino acids would you expect to surround it? 

Choose “Glycine 307 and Neighbors” on the crystallographic model exercise. 

15. What amino acids is Gly307 in contact with? 

16. What type of amino acids are those? 

A human mutation leading to a severe and untreatable case of homocystinurea is caused by the 
equivalent of G1056A mutation in yeast. 

17. What amino acid would be created in yeast with that substitution? 

18. Is a mutation causing this amino acid substitution more likely in humans or in yeast? Why? 

19. What would be the effect of this mutation be on the tertiary structure of CBS? Why? 

This mutation in humans does not respond to the vitamin B6 treatment.  

20. What are the possible reasons that one mutation would respond to treatment and another would 
not? 

C.  Transcription and Translation—Conclusions 

1.  Where is all the information needed to properly execute transcription and translation recorded?  

2.  Is all this information accessible to the same machinery? 

3.  Is the stop codon in position 1839 where transcription of the CBS gene stops? Why or why not? 

U 
U  UUU  phe 
UUC  phe 
UUA  leu 
UUG  leu 
C  CUU  leu 
CUC  leu 
CUA  leu 
CUG  leu 
A  AUU  ile 
AUC  ile 
AUA  ile 
AUG  met 
G  GUU  val 
GUC  val 
GUA  val 
GUG  val 

The Genetic Code 
C 
A 
UAU  tyr 
ser 
UAC  tyr 
ser 
ser 
UAA  STOP 
ser 
UAG  STOP 
CAU  his 
pro 
CAC  his 
pro 
CAA  gln 
pro 
CAG  gln 
pro 
AAU  asn 
thr 
AAC  asn 
thr 
AAA  lys 
thr 
AAG  lys 
thr 
GAU  asp 
ala 
GAC  asp 
ala 
GAA  glu 
ala 
GAG  glu 
ala 

UCU 
UCC 
UCA 
UCG 
CCU 
CCC 
CCA 
CCG 
ACU 
ACC 
ACA 
ACG 
GCU 
GCC 
GCA 
GCG 

G 
UGU  cys 
UGC  cys 
UGA  STOP  
UGG  trp 
CGU  arg 
CGC  arg 
CGA  arg 
CGG  arg 
AGU  ser 
AGC  ser 
AGA  arg 
AGG  arg 
GGU  gly 
GGC  gly 
GGA  gly 
GGG  gly 

U 
C 
A 
G 
U 
C 
A 
G 
U 
C 
A 
G 
U 
C 
A 
G 

STRUCTURES OF AMINO ACIDS 
at pH 7.0 

-
O 

O

C 
H
H  C  CH2CH2CH2  N 
NH3 
+ 
ARGININE 
(arg) 

NH2 

C 
NH2
+ 

-

O 

O

C 

O 

C
H C CH2
NH3 
+ 
ASPARAGINE 
(asN) 

NH2


-
O


O

C

O 
-
O

C
H C CH2 
NH3 
+

ASPARTIC ACID 
(asp) 

-
O	

O

C 

O 
-

O 

C 
H  C  CH2CH2 
NH3 
+ 
GLUTAMIC ACID 
(glu)	

-
O 

O

C
H  C  CH2CH2  C 
NH3 
+
GLUTAMINE 
(glN) 

O 

NH2 

-
O 

O

C
H  C H
NH3

+

GLYCINE 
(gly) 

-
O 

O

C	
H  C  CH3 
NH3 
+ 
ALANINE 
(ala) 

-
O 

O

SH 

C 
H  C  CH2 
NH3 
+
CYSTEINE 
(cys) 

H 
+ 
N 

-
O 

O

C 
H  C  CH2 
NH3 
+


C
H

HISTIDINE 
(his)


C 

N 

H

H

O

-
O 
HC	
H  C  C  CH2CH3 
NH3  CH3 
+
ISOLEUCINE 
(ile) 

-
O	

O

H 
C 
H  C  CH2  C  CH3 
CH3 
NH3 
+	
LEUCINE 
(leu) 

-
O	

O

C
H  C  CH2CH2  S CH3 
NH3	
+
METHIONINE 
(met)	

-
O

O

H 

H 

H 

C 
H  C  CH2 
NH3 
+

H 
H 
PHENYLALANINE 
(phe) 
H

H

-
O

O

O

C	
H C CH2 C 
NH3 
+ 

-

O

C  H 
H C C CH3 
NH3  OH 
+ 
H 
THREONINE  TRYPTOPHAN 
(thr) 
(trp) 

N

H 

H 

H

-
O 

O

C 
H  C  CH2 
NH3 
+ 

-
O 

O

+

C
H  C  CH2CH2CH2CH2  NH3
NH3
+ 
LYSINE 
(lys)


-
O 

O

C 
H C CH2  OH 
NH3

+

SERINE

(ser)


-
O 

O

CH3

C
CH3
H C
C 
NH3  H
+
VALINE 
(val)

-
O 

O

C

CH2 

C

CH2 

H 
H 
N

H  +  CH2 
PROLINE 
(pro) 

H 

H 

OH 

H

H
TYROSINE 
(tyr) 

